TRUST IN EXCELLENCE
Vifor Pharma Group, formerly Galenica Group, is a global specialty pharmaceuticals company that researches, develops, produces and markets its own pharmaceutical products and is the partner of choice for innovative, patient-focused solutions.
The Galenica Group changed its name to Vifor Pharma Group at the Annual General Meeting in May 2017, with the vision of becoming a Global Leader in Iron Deficiency, Nephrology and Cardio-Renal Therapies.
Relypsa, Inc., a Vifor Pharma Company, is a biopharmaceutical company focused on the discovery, development and commercialization of polymeric medicines for patients with conditions that are often overlooked and undertreated.
Vifor Pharma is a leader in iron deficiency therapy, with a history dating back to 1872 when pharmacist Caspar Friedrich Hausmann opened a pharmacy in St. Gallen, Switzerland, and developed infusion preparations and pharmaceutical specialities.
We have a broad and diversified offering in nephrology and cardio-renal therapies.
READ MORE: VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA
The Vifor Pharma Infectious Diseases / OTX franchise focuses on a range of over-the-counter and OTX (prescribed non-prescription) products.
Resources for media, including media releases, images and videos, financial and annual reporting, and more.
Half Year Results 2017
WORKING AT VIFOR PHARMA
Together we are making a difference: Finding new solutions, delivering high-quality products, driving scientific excellence and helping people around the world.
Download Annual Report 2016 (Galenica Group)
Vifor Pharma Management Ltd.
+41 58 851 80 00